Nootropics Index - Save on smarter supplements
Nootropics>Botanical & herbal supplements>Ginkgo Biloba
Botanical & herbal supplements

Ginkgo Biloba

Ginkgo biloba L. leaf extract

Ginkgo Biloba is a botanical leaf supplement sold as standardized extracts, tablets, capsules and bulk powders. It has substantial human research in older-adult and clinical cognitive contexts, but NCCIH says brain-health claims for healthy people remain uncertain and product evidence is mixed. Compare listings by standardized extract dose, marker compounds, ginkgolic-acid limits, COA quality and anticoagulant/surgery/pregnancy cautions rather than by bulk powder price alone.

Focus SupportMemory SupportHealthy AgingAntioxidant PathwaysBlood Flow SupportWhole HerbStandardized Extract
Updated August 2026/6 min read/6 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What Ginkgo Biloba is

1

Ginkgo Biloba products use Ginkgo biloba L. leaf material, commonly as an extract or powder and sometimes supplied in tablet or capsule formats. This page separates botanical forms and their form-dependent evidence; it does not present ginkgo as a generic memory pill or stimulant.

02

Names, aliases and forms

Common NamesGinkgo Biloba; Ginkgo; Maidenhair tree
Latin NameGinkgo biloba L.
Plant PartGinkgo leaf
Extract NameGinkgo biloba leaf dry extract
Active Constituentsginkgo flavone glycosides; terpene lactones
03

Mechanisms of action

Mechanisms are plausible, not proof of broad nootropic effects

2

EMA's public summary describes possible mechanisms around blood-flow regulation and neutralising oxygen free radicals, but also says the exact medicinal mechanism is not fully understood. Keep these mechanisms as context for standardized extracts, not as stand-alone benefit claims.

04

Potential effects and evidence map

Ginkgo biloba leaf extract is one of the better-studied botanical supplements, but the evidence does not map neatly onto healthy nootropic use. NCCIH summarizes no conclusive evidence for health conditions overall, uncertain effects on cognitive performance in healthy people, and inconsistent evidence in cognitive-impairment contexts. For shoppers, the most actionable evidence issue is form: standardized dry extract data should not be generalized to whole-leaf powder, organic powder or unclear proprietary blends.

Effect domainMagnitudeGrade
Memory / learning1
CumulativeConfidence: Medium

Ginkgo has population-specific human cognitive research, but it should not be presented as a proven memory enhancer for healthy adults.

Note NCCIH reports uncertain healthy-person cognitive-performance effects and inconsistent evidence in cognitive-impairment contexts.

2/5
C
Focus / attention5
UnknownConfidence: Low

Healthy-adult focus and attention claims are weak and inconsistent.

Note The healthy-adult systematic review found low certainty and methodologic limitations across supplement ingredients marketed for cognitive performance.

1/5
C
Cellular / long-term brain support2
CumulativeConfidence: Medium

Blood-flow and antioxidant mechanisms are plausible but should not be converted into broad brain-health promises.

Note Use as mechanism context only; product copy should stay evidence-limited and form-specific.

1/5
D
Mental energy / wakefulness5
UnknownConfidence: Medium

Ginkgo is not established as a reliable mental-energy product.

Note Avoid borrowing stimulant-style onset or wakefulness language from unrelated nootropics.

0/5
E
05

Typical dosages and timing

Defined dry extract3120-240 mg single; 240 mg daily

The EMA/HMPC monograph lists a 120-240 mg single dose and a 240 mg daily dose for a defined ginkgo dry-extract herbal medicinal product. This is regulatory monograph context, not a consumer supplement recommendation; it does not translate to raw leaf powder, bulk material, or products without disclosed marker compounds.

06

Timing & effect horizon

Effect horizonUnknown
Unknown
No reliable acute nootropic timeline5

This page does not assign an acute cognitive-effect onset or duration because healthy-adult cognition evidence is low-certainty and inconsistent. It does not infer a consumer timing claim from a product label.

Study-course context3

The EMA monograph uses repeated-use and follow-up language for specific adult herbal medicinal products. That is regulatory study-course context only; it does not establish a public supplement cycle, acute effect duration or nootropic onset claim.

07

Safety, side effects and risk profile

Bleeding, pregnancy and crude plant cautions matter1
NCCIH describes ginkgo leaf extract as generally well tolerated for most adults in moderate amounts, but flags dizziness, gastrointestinal symptoms, headache, bleeding risk with anticoagulants and possible pregnancy risk. It also notes fresh seeds are toxic and serious side effects have occurred with seeds or crude plant material.
Interaction risk3
Confidence: High

Bleeding and medication-interaction cautions are central, especially with anticoagulants, antiplatelets or peri-surgery use.

Note Meaningful concern for people using anticoagulant or antiplatelet medicines or preparing for surgery; it does not define the healthy-adult base risk.

3/5
B
Headache / dizziness1
Confidence: Medium

Headache and dizziness are common tolerability issues reported for ginkgo leaf extract.

Note Keep this practical for shoppers comparing capsules and powders; side effects are not limited to high-dose products.

2/5
B
GI discomfort1
Confidence: Medium

Gastrointestinal symptoms can occur with ginkgo leaf extract.

Note Extract strength and serving size can change tolerability; do not compare whole-leaf and standardized extract gram-for-gram.

2/5
B
Pregnancy / lactation caution1
Confidence: Medium

Ginkgo may be unsafe during pregnancy, and breastfeeding safety is not well established.

Note NCCIH flags possible early labor or extra bleeding near delivery and limited breastfeeding information.

3/5
B
Cardiovascular caution2
Confidence: Medium

Bleeding events have been reported, so cardiovascular and vascular-medication contexts need review.

Note This is a bleeding and vascular-medication context, not evidence of an inherent cardiovascular risk or benefit for healthy adults.

2/5
B
Evidence uncertainty5
Confidence: High

Healthy nootropic claims are less certain than the marketing often implies.

Note NCCIH and Crawford 2021 both support conservative healthy-adult cognition wording.

2/5
A
Legal / regulatory risk2
Confidence: Medium

U.S. supplement products and EU herbal medicines sit under different regulatory frameworks.

Note Do not globalize EMA/HMPC medicinal-use language into U.S. supplement claims or assume all products are licensed herbal medicines.

2/5
B
08

Interactions and cautions

Interaction check3

Ginkgo preparations may increase bleeding susceptibility. The EMA/HMPC monograph says that people with a bleeding tendency or concomitant anticoagulant or antiplatelet treatment should consult a doctor; it also notes a precaution before surgery. Product pages should make this visible rather than hiding it in fine print.

09

Legal and regulatory status

United States6

As of 2026-08-01, products marketed in the United States as dietary supplements are not FDA-approved for safety or effectiveness before sale.

European Union2

As of 2026-08-01, EMA/HMPC material describes specific ginkgo leaf herbal-medicinal preparations. EU Member State national authorities assess applications for medicines containing ginkgo leaf; this does not establish approval for every powder, capsule or imported listing.

10

Practical buying and quality notes

  • The active catalog includes extract and powder listings in tablet/capsule and powder formats. Separate standardized extracts from organic or whole-leaf powder, and exclude malformed zero-price entries or stale prices from comparisons. Compare standardized extract products by disclosed extract amount and marker compounds; compare powders only after confirming whether they are extract or leaf powder.3
  • For a defined ginkgo extract, compare the disclosed plant part, extract identity and marker-compound information rather than relying on a shorthand alone. EMA assessment materials describe refined dry-extract ranges around 22-27% flavone glycosides, 5-7% terpene lactones and ginkgolic acids below 5 ppm.4
11

FAQ

Does Ginkgo Biloba work as a nootropic?

1

NCCIH says it is uncertain whether ginkgo affects cognitive performance in healthy people, and notes that much of this research is low quality.

What dose should I compare for Ginkgo Biloba?

3

The EMA/HMPC monograph lists a 120-240 mg single dose and a 240 mg daily dose for a defined dry-extract herbal medicinal product. That is not a consumer supplement recommendation. Whole-leaf powder, organic powder, bulk extract powder and products without disclosed marker compounds need separate label-based comparison.

How long does Ginkgo Biloba take to work?

3

A reliable acute nootropic onset is not established. Most serious ginkgo evidence involves repeated daily use over weeks or months, so duration should be described as study-course context rather than an effect-duration promise.

Is Ginkgo Biloba extract the same as ginkgo leaf powder?

4

No. Standardized extract is usually compared by extract milligrams and marker compounds, while leaf powder is plant material by weight. A cheaper price per gram does not mean the same active-constituent exposure.

Who should be cautious with Ginkgo Biloba?

1

People using anticoagulant medicines, people who are pregnant or may be pregnant, people who are breastfeeding, and people with complex medication routines should discuss ginkgo with a clinician or pharmacist. This page is for comparison and evidence review, not medical clearance.

How should I compare the best Ginkgo Biloba price?

4

Normalize by the right unit first: extract tablets by milligrams of standardized extract per serving, powders by confirmed extract or leaf-powder identity, and bulk sizes only after checking marker compounds, ginkgolic-acid limits, COA freshness, shipping and serving math.

12

References

  1. National Center for Complementary and Integrative Health. Ginkgo: Usefulness and Safety.
  2. European Medicines Agency. Ginkgo folium - herbal medicinal product.
  3. EMA/HMPC. European Union herbal monograph on Ginkgo biloba L., folium. EMA/HMPC/321097/2012.
  4. EMA/HMPC. Assessment report on Ginkgo biloba L., folium. EMA/HMPC/321095/2012.
  5. Crawford C, Boyd C, Deuster PA. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. J Altern Complement Med. 2021;27(11):940-958.
  6. U.S. Food and Drug Administration. Information for Consumers on Using Dietary Supplements.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.